The cyclooxygenase-2-selective inhibitors rofecoxib and celecoxib prevent colorectal neoplasia occurrence and recurrence

E Rahme, AN Barkun, Y Toubouti, M Bardou - Gastroenterology, 2003 - Elsevier
BACKGROUND & AIMS:: Colorectal cancer is one of the leading causes of cancer death.
Most colorectal cancers are believed to develop from colorectal adenomas. We examined …
被引用次数：144 相关文章

[引用][C] The cyclooxygenase-2-selective inhibitors rofecoxib and celecoxib prevent colorectal neoplasia occurrence and recurrence

E RAHME, AN BARKUN, Y TOUBOUTI… - … (New York, NY …, 2003 - pascal-francis.inist.fr
The cyclooxygenase-2-selective inhibitors rofecoxib and celecoxib prevent colorectal
neoplasia occurrence and recurrence CNRS Inist Pascal-Francis CNRS Pascal and Francis …

[引用][C] The cyclooxygenase-2-selective inhibitors rofecoxib and celecoxib prevent colorectal neoplasia occurrence and recurrence

E RAHME - Gastroenterology, 2003 - cir.nii.ac.jp

The cyclooxygenase-2-selective inhibitors rofecoxib and celecoxib prevent colorectal neoplasia occurrence and recurrence.

E Rahme, AN Barkun, Y Toubouti, M Bardou - Gastroenterology, 2003 - europepmc.org
BACKGROUND & AIMS: Colorectal cancer is one of the leading causes of cancer death.
Most colorectal cancers are believed to develop from colorectal adenomas. We examined …

The cyclooxygenase-2-selective inhibitors rofecoxib and celecoxib prevent colorectal neoplasia occurrence and recurrence

E Rahme, AN Barkun, Y Toubouti, M Bardou - Gastroenterology, 2003 - gastrojournal.org
Abstract Background & Aims: Colorectal cancer is one of the leading causes of cancer
death. Most colorectal cancers are believed to develop from colorectal adenomas. We …

The cyclooxygenase-2-selective inhibitors rofecoxib and celecoxib prevent colorectal neoplasia occurrence and recurrence

E Rahme, AN Barkun, Y Toubouti… - …, 2003 - pubmed.ncbi.nlm.nih.gov
Background & aims Colorectal cancer is one of the leading causes of cancer death. Most
colorectal cancers are believed to develop from colorectal adenomas. We examined the …

[引用][C] The cyclooxygenase-2-selective inhibitors rofecoxib and celecoxib prevent colorectal neoplasia occurrence and recurrence

E RAHME - Gastroenterology, 2003 - cir.nii.ac.jp
The cyclooxygenase-2-selective inhibitors rofecoxib and celecoxib prevent colorectal neoplasia
occurrence and recurrence | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …

[引用][C] The cyclooxygenase-2-selective inhibitors rofecoxib and celecoxib prevent colorectal neoplasia occurrence and recurrence

E RAHME, AN BARKUN, Y TOUBOUTI, M BARDOU - Gastroenterology, 2003 - Wiley